Stocks Sarepta Therapeutics Shares Jump 32% on Expanded FDA Approval for Duchenne Gene Therapy By Investing.comJune 21, 2024 Investing.com – Sarepta Therapeutics (NASDAQ:), a pioneer in genetic precision medicine for rare diseases, saw…
Finance Octopus Group Chris Hulatt Used ‘Terminator Gene’ to Launch $16.7 Billion Investment CompanyApril 27, 2024 Chris Hulatt was a graduate fund manager trainee at Mercury Asset Management (now Merrill) when…
